|
|
||||||||
Departments of Nuclear Medicine and Internal Medicine, Seoul National University Hospital, Seoul, Korea
Correspondence: For correspondence or reprints contact: June-Key Chung, MD, Department of Nuclear Medicine, Seoul National University Hospital, 28 Yungun-dong, Chongno-ku, Seoul 110-744, Korea.
ABSTRACT
Bone marrow is the primary site for many hematologic disorders. To date, however, no suitable bone marrow imaging method has been found. The present study investigates the usefulness of bone marrow immunoscintigraphy using 99mTc-labeled antigranulocyte antibody (anti-NCA-95) in 31 patients with hematologic disorders. Methods: One milligram of antibody labeled with 259370 MBq 99mTc was injected intravenously, and bone marrow images were taken 4 hr later. We also calculated the uptake ratios of lumbar bone marrow-to-background (L/B) and ilium-to-background (I/B). Results: Of 15 patients with aplastic anemia, 7 showed diffusely decreased antibody uptake (L/B = 2.3 ± 0.8, I/B = 3.0 ± 0.8) compared to control patients (n = 21, L/B = 8.2 ± 2.5, I/B = 10.3 ± 3.1). Six patients had both decreased and increased uptake areas and two had normal to slightly increased uptake. Of those patients receiving various types of therapy for aplastic anemia, all but one showed increased or irregular uptake. The degree of antibody uptake in the bone marrow correlated with peripheral blood analyses (hemoglobin, white blood cells, platelets). Of six patients with myelodysplastic syndrome, four had irregular uptake and two diffusely decreased uptake. Four patients with myelogenous leukemia showed normal uptake, whereas two with lymphocytic leukemia had decreased uptake. Patients with iron deficiency anemia, pure red cell aplasia or thalassemia minor exhibited normal uptake with bone marrow expansion. Conclusion: Immunoscintigraphy with antigranulocyte antibody is a useful method for evaluating the bone marrow status of patients with various hematologic disorders.
Key Words: hematologic disorder bone marrow scintigraphy technetium-99m-anti-NCA-95 aplastic anemia myelodysplastic syndrome
This article has been cited by other articles:
![]() |
A. Agool, B. W. Schot, P. L. Jager, and E. Vellenga 18F-FLT PET in Hematologic Disorders: A Novel Technique to Analyze the Bone Marrow Compartment J. Nucl. Med., October 1, 2006; 47(10): 1592 - 1598. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Carr, S. F. Barrington, B. Madan, M. J. O'Doherty, C. A.B. Saunders, J. van der Walt, and A. R. Timothy Detection of Lymphoma in Bone Marrow by Whole-Body Positron Emission Tomography Blood, May 1, 1998; 91(9): 3340 - 3346. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |